Doximity [DOCS] vs Tempus AI [TEM] Detailed Stock Comparison
Doximity
NYSE
Loading...
Tempus AI
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Doximity wins in 9 metrics, Tempus AI wins in 8 metrics, with 0 ties. Doximity appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Doximity | Tempus AI | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 52.84 | 33.14 | Tempus AI |
| Price-to-Book Ratio | 11.30 | 39.94 | Doximity |
| Debt-to-Equity Ratio | 1.16 | 275.63 | Doximity |
| PEG Ratio | 51.95 | -0.34 | Tempus AI |
| EV/EBITDA | 44.08 | -74.58 | Tempus AI |
| Profit Margin (TTM) | 39.88% | -20.98% | Doximity |
| Operating Margin (TTM) | 37.48% | -19.00% | Doximity |
| EBITDA Margin (TTM) | 37.48% | N/A | N/A |
| Return on Equity | 24.25% | -97.95% | Doximity |
| Return on Assets (TTM) | 13.13% | -11.51% | Doximity |
| Free Cash Flow (TTM) | $266.74M | $-211.17M | Doximity |
| 1-Year Return | 82.18% | 45.01% | Doximity |
| Price-to-Sales Ratio (TTM) | 19.64 | 13.00 | Tempus AI |
| Enterprise Value | $10.75B | $12.09B | Tempus AI |
| EV/Revenue Ratio | 18.23 | 12.70 | Tempus AI |
| Gross Profit Margin (TTM) | 89.18% | 61.99% | Doximity |
| Revenue per Share (TTM) | $3 | $6 | Tempus AI |
| Earnings per Share (Diluted) | $1.17 | $2.15 | Tempus AI |
| Beta (Stock Volatility) | 1.36 | N/A | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Doximity vs Tempus AI Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Doximity | 2.50% | -2.18% | 4.96% | 11.43% | -16.42% | 21.60% |
| Tempus AI | 3.06% | 21.21% | 32.01% | 17.86% | -9.97% | 115.42% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Doximity | 82.18% | 97.30% | 16.35% | 16.35% | 16.35% | 16.35% |
| Tempus AI | 45.01% | 83.30% | 83.30% | 83.30% | 83.30% | 83.30% |
Performance & Financial Health Analysis: Doximity vs Tempus AI
| Metric | DOCS | TEM |
|---|---|---|
| Market Information | ||
| Market Cap | $11.58B | $12.38B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,390,453 | 9,388,110 |
| 90 Day Avg. Volume | 1,815,488 | 8,782,537 |
| Last Close | $65.13 | $73.78 |
| 52 Week Range | $34.34 - $85.21 | $31.36 - $91.45 |
| % from 52W High | -23.57% | -19.32% |
| All-Time High | $107.79 (Sep 06, 2021) | $91.45 (Feb 10, 2025) |
| % from All-Time High | -39.58% | -19.32% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.90% |
| Quarterly Earnings Growth | 0.29% | 0.90% |
| Financial Health | ||
| Profit Margin (TTM) | 0.40% | -0.21% |
| Operating Margin (TTM) | 0.37% | -0.19% |
| Return on Equity (TTM) | 0.24% | -0.98% |
| Debt to Equity (MRQ) | 1.16 | 275.63 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.47 | $1.78 |
| Cash per Share (MRQ) | $4.49 | $1.68 |
| Operating Cash Flow (TTM) | $294.12M | $-52,047,000 |
| Levered Free Cash Flow (TTM) | $231.29M | $18.93M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Doximity vs Tempus AI
| Metric | DOCS | TEM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 52.84 | 33.14 |
| Forward P/E | 51.95 | -101.79 |
| PEG Ratio | 51.95 | -0.34 |
| Price to Sales (TTM) | 19.64 | 13.00 |
| Price to Book (MRQ) | 11.30 | 39.94 |
| Market Capitalization | ||
| Market Capitalization | $11.58B | $12.38B |
| Enterprise Value | $10.75B | $12.09B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 18.23 | 12.70 |
| Enterprise to EBITDA | 44.08 | -74.58 |
| Risk & Other Metrics | ||
| Beta | 1.36 | N/A |
| Book Value per Share (MRQ) | $5.47 | $1.78 |
Financial Statements Comparison: Doximity vs Tempus AI
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | DOCS | TEM |
|---|---|---|
| Revenue/Sales | $145.91M | $255.74M |
| Cost of Goods Sold | $15.79M | $100.53M |
| Gross Profit | $130.12M | $155.20M |
| Research & Development | $26.80M | $69.27M |
| Operating Income (EBIT) | $54.52M | $-68.69M |
| EBITDA | $57.31M | $-73.98M |
| Pre-Tax Income | $64.15M | $-112.33M |
| Income Tax | $10.83M | $-46.18M |
| Net Income (Profit) | $53.32M | $-68.04M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | DOCS | TEM |
|---|---|---|
| Cash & Equivalents | $209.61M | $151.60M |
| Total Current Assets | $1.09B | $573.97M |
| Total Current Liabilities | $156.26M | $336.47M |
| Long-Term Debt | $10.19M | $848.33M |
| Total Shareholders Equity | $1.08B | $326.19M |
| Retained Earnings | $186.89M | $-2.22B |
| Property, Plant & Equipment | $8.89M | $168.53M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | DOCS | TEM |
|---|---|---|
| Operating Cash Flow | $119.90M | $-109.53M |
| Capital Expenditures | $0 | $-2.07M |
| Free Cash Flow | $96.98M | $-109.00M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-26.79M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | DOCS | TEM |
|---|---|---|
| Shares Short | 4.07M | 23.17M |
| Short Ratio | 2.65 | 2.59 |
| Short % of Float | 0.03% | 0.18% |
| Average Daily Volume (10 Day) | 2,390,453 | 9,388,110 |
| Average Daily Volume (90 Day) | 1,815,488 | 8,782,537 |
| Shares Outstanding | 188.88M | 161.98M |
| Float Shares | 133.18M | 101.43M |
| % Held by Insiders | 0.02% | 0.43% |
| % Held by Institutions | 0.96% | 0.42% |
Dividend Analysis & Yield Comparison: Doximity vs Tempus AI
| Metric | DOCS | TEM |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |